Smart Contracts for Data Sharing in Drug Development a Systematic Review of Security and Transparent Measurement

Authors

  • Annastasya Nabila Elsa Wulandari Universitas Harapan Bangsa
  • Purwono Universitas Harapan Bangsa

DOI:

https://doi.org/10.59247/jahir.v2i1.288

Keywords:

Blockchain, Iot, Data Security, Drug Development, Smart Contract

Abstract

This systematic literature review explores the role of smart contracts in improving data sharing for drug development, with an emphasis on security and transparency. Using blockchain technology, smart contracts offer a decentralized tracking mechanism for pharmaceutical supply chains, addressing challenges related to drug authentication and supply chain optimization. The review examined 52 studies using the PRISMA methodology, highlighting the automation of data exchange, reduced reliance on external parties, and acceleration of operational processes. Advanced encryption and strict access controls in smart contracts strengthen data security, ensuring patient confidentiality and compliance with medical data regulations. Despite technical and regulatory barriers, smart contracts promise significant improvements in operational efficiency, transparency, and collaboration among stakeholders in drug development. This study emphasizes the need for standardized protocols, further empirical research, and strategic implementation to fully leverage the potential of smart contracts in the pharmaceutical industry. Integration of these technologies can accelerate clinical trials and improve data reliability, thereby enhancing the safety and effectiveness of the drug development process.

References

K. C. Bandhu, R. Litoriya, P. Lowanshi, M. Jindal, L. Chouhan, and S. Jain, “Making drug supply chain secure traceable and efficient: a Blockchain and smart contract-based implementation,” Multimed Tools Appl, vol. 82, no. 15, pp. 23541–23568, Jun. 2023, doi: 10.1007/s11042-022-14238-4.

S. R. Sama et al., “Targeting patients for early COVID-19 therapy; Pre-infection metabolic dysfunction, polycystic ovary syndrome and risk of severe disease in patients under 65: A Massachusetts community-based observational study,” PLoS One, vol. 18, no. 6 June, Jun. 2023, doi: 10.1371/journal.pone.0287430.

A. Premkumar and C. Srimathi, “Application of Blockchain and IoT towards Pharmaceutical Industry,” in 2020 6th International Conference on Advanced Computing and Communication Systems (ICACCS), IEEE, Mar. 2020, pp. 729–733. doi: 10.1109/ICACCS48705.2020.9074264.

N. Zakari et al., “Blockchain technology in the pharmaceutical industry: a systematic review,” PeerJ Comput Sci, vol. 8, p. e840, Mar. 2022, doi: 10.7717/peerj-cs.840.

S. Callaghan, “On the Importance of Data Transparency,” Patterns, vol. 1, no. 4, p. 100070, Jul. 2020, doi: 10.1016/j.patter.2020.100070.

N. Abraham and R. Ramar, “Secure Data Sharing with Interplanetary File System for Pharmaceutical Data,” 2021, pp. 263–289. doi: 10.1007/978-3-030-72236-4_11.

T. Nugent, D. Upton, and M. Cimpoesu, “Improving data transparency in clinical trials using blockchain smart contracts,” F1000Res, vol. 5, p. 2541, Oct. 2016, doi: 10.12688/f1000research.9756.1.

P. Xi, X. Zhang, L. Wang, W. Liu, and S. Peng, “A Review of Blockchain-Based Secure Sharing of Healthcare Data,” Applied Sciences, vol. 12, no. 15, p. 7912, Aug. 2022, doi: 10.3390/app12157912.

R. Akkaoui, “Blockchain for the Management of Internet of Things Devices in the Medical Industry,” IEEE Trans Eng Manag, vol. 70, no. 8, pp. 2707–2718, Aug. 2023, doi: 10.1109/TEM.2021.3097117.

V. Upadrista, S. Nazir, and H. Tianfield, “Secure data sharing with blockchain for remote health monitoring applications: a review,” J Reliab Intell Environ, vol. 9, no. 3, pp. 349–368, Sep. 2023, doi: 10.1007/s40860-023-00204-w.

R. Croft, Y. Xie, and M. A. Babar, “Data Preparation for Software Vulnerability Prediction: A Systematic Literature Review,” IEEE Transactions on Software Engineering, vol. 49, no. 3, pp. 1044–1063, Mar. 2023, doi: 10.1109/TSE.2022.3171202.

M. Regona, T. Yigitcanlar, B. Xia, and R. Y. M. Li, “Opportunities and Adoption Challenges of AI in the Construction Industry: A PRISMA Review,” Journal of Open Innovation: Technology, Market, and Complexity, vol. 8, no. 1, p. 45, Mar. 2022, doi: 10.3390/joitmc8010045.

S. Saeidnia and M. Abdollahi, “Peer review processes and related issues in scholarly journals,” DARU Journal of Pharmaceutical Sciences, vol. 23, no. 1, p. 21, Dec. 2015, doi: 10.1186/s40199-015-0099-4.

M. J. Page et al., “The PRISMA 2020 statement: an updated guideline for reporting systematic reviews,” BMJ, p. n71, Mar. 2021, doi: 10.1136/bmj.n71.

I. A. Omar, R. Jayaraman, K. Salah, and M. C. E. Simsekler, “Exploiting Ethereum Smart Contracts for Clinical Trial Management,” in 2019 IEEE/ACS 16th International Conference on Computer Systems and Applications (AICCSA), IEEE, Nov. 2019, pp. 1–6. doi: 10.1109/AICCSA47632.2019.9035341.

“Research Methods in Psychology,” J Environ Psychol, vol. 14, no. 4, p. 335, Dec. 1994, doi: 10.1016/S0272-4944(05)80228-2.

A. Islam, L. Alcock, K. Nazarpour, L. Rochester, and A. Pantall, “Effect of Parkinson’s disease and two therapeutic interventions on muscle activity during walking: a systematic review,” NPJ Parkinsons Dis, vol. 6, no. 1, p. 22, Sep. 2020, doi: 10.1038/s41531-020-00119-w.

K. Ham and H. Lim, “Career Maturity and Quality of Life in Korean Adolescents: A Cross‐Lagged Panel Design,” Career Dev Q, vol. 65, no. 3, pp. 250–263, Sep. 2017, doi: 10.1002/cdq.12096.

S. Saeidnia and M. Abdollahi, “Peer review processes and related issues in scholarly journals,” DARU Journal of Pharmaceutical Sciences, vol. 23, no. 1, p. 21, Dec. 2015, doi: 10.1186/s40199-015-0099-4.

A. I. Alsalami, “Literature review as a key step in research processes: case study of MA dissertations written on EFL of Saudi context,” Saudi Journal of Language Studies, vol. 2, no. 3, pp. 153–169, Aug. 2022, doi: 10.1108/SJLS-04-2022-0044.

M. Regona, T. Yigitcanlar, B. Xia, and R. Y. M. Li, “Opportunities and Adoption Challenges of AI in the Construction Industry: A PRISMA Review,” Journal of Open Innovation: Technology, Market, and Complexity, vol. 8, no. 1, p. 45, Mar. 2022, doi: 10.3390/joitmc8010045.

I. B. Bengono, “Governance and Organisational Flexibility at the Junction of African MFIs’ Sustainability Issues,” Global Journal of Flexible Systems Management, vol. 23, no. S1, pp. 39–50, Dec. 2022, doi: 10.1007/s40171-022-00333-w.

M. J. Page et al., “The PRISMA 2020 statement: an updated guideline for reporting systematic reviews,” BMJ, p. n71, Mar. 2021, doi: 10.1136/bmj.n71.

B. K. Beaulieu-Jones et al., “Privacy-Preserving Generative Deep Neural Networks Support Clinical Data Sharing,” Circ Cardiovasc Qual Outcomes, vol. 12, no. 7, Jul. 2019, doi: 10.1161/CIRCOUTCOMES.118.005122.

B. Shen, J. Guo, and Y. Yang, “MedChain: Efficient Healthcare Data Sharing via Blockchain,” Applied Sciences, vol. 9, no. 6, p. 1207, Mar. 2019, doi: 10.3390/app9061207.

U. Marx, “Biology-inspired microphysiological systems to advance medicines for patient benefit and animal welfare,” ALTEX, 2020, doi: 10.14573/altex.2001241.

F. Alam Khan, M. Asif, A. Ahmad, M. Alharbi, and H. Aljuaid, “Blockchain technology, improvement suggestions, security challenges on smart grid and its application in healthcare for sustainable development,” Sustain Cities Soc, vol. 55, p. 102018, Apr. 2020, doi: 10.1016/j.scs.2020.102018.

I. A. Omar, R. Jayaraman, M. S. Debe, K. Salah, I. Yaqoob, and M. Omar, “Automating Procurement Contracts in the Healthcare Supply Chain Using Blockchain Smart Contracts,” IEEE Access, vol. 9, pp. 37397–37409, 2021, doi: 10.1109/ACCESS.2021.3062471.

I. Haq and O. Muselemu, “Blockchain Technology in Pharmaceutical Industry to Prevent Counterfeit Drugs,” Int J Comput Appl, vol. 180, no. 25, pp. 8–12, Mar. 2018, doi: 10.5120/ijca2018916579.

G. Gürsoy, C. M. Brannon, and M. Gerstein, “Using Ethereum blockchain to store and query pharmacogenomics data via smart contracts,” BMC Med Genomics, vol. 13, no. 1, p. 74, Dec. 2020, doi: 10.1186/s12920-020-00732-x.

M. Arumugam, S. Deepa, G. R. Sreekanth, G. Arun, and S. Nilesh, “Counterfeit drugs prevention using block chain techniques,” IOP Conf Ser Mater Sci Eng, vol. 1055, no. 1, p. 012109, Feb. 2021, doi: 10.1088/1757-899X/1055/1/012109.

N. Josias Gbètoho Saho and E. C. Ezin, “Developing a Digital Healthcare Book based on the Blockchain Technology,” in 2021 International Symposium on Electrical, Electronics and Information Engineering, New York, NY, USA: ACM, Feb. 2021, pp. 617–622. doi: 10.1145/3459104.3459203.

G. Royston, N. Pakenham-Walsh, and C. Zielinski, “Universal access to essential health information: accelerating progress towards universal health coverage and other SDG health targets,” BMJ Glob Health, vol. 5, no. 5, p. e002475, May 2020, doi: 10.1136/bmjgh-2020-002475.

I. T. Agaku, A. O. Adisa, O. A. Ayo-Yusuf, and G. N. Connolly, “Concern about security and privacy, and perceived control over collection and use of health information are related to withholding of health information from healthcare providers,” Journal of the American Medical Informatics Association, vol. 21, no. 2, pp. 374–378, Mar. 2014, doi: 10.1136/amiajnl-2013-002079.

A. Aftab, C. Chrysostomou, H. K. Qureshi, and S. Rehman, “Holo-Block Chain: A Hybrid Approach for Secured IoT Healthcare Ecosystem,” in 2022 18th International Conference on Wireless and Mobile Computing, Networking and Communications (WiMob), IEEE, Oct. 2022, pp. 243–250. doi: 10.1109/WiMob55322.2022.9941553.

N. Josias Gbètoho Saho and E. C. Ezin, “Developing a Digital Healthcare Book based on the Blockchain Technology,” in 2021 International Symposium on Electrical, Electronics and Information Engineering, New York, NY, USA: ACM, Feb. 2021, pp. 617–622. doi: 10.1145/3459104.3459203.

G. Gürsoy, C. M. Brannon, and M. Gerstein, “Using Ethereum blockchain to store and query pharmacogenomics data via smart contracts,” BMC Med Genomics, vol. 13, no. 1, p. 74, Dec. 2020, doi: 10.1186/s12920-020-00732-x.

N. Fotiou, I. Pittaras, V. A. Siris, S. Voulgaris, and G. C. Polyzos, “Secure IoT Access at Scale Using Blockchains and Smart Contracts,” in 2019 IEEE 20th International Symposium on “A World of Wireless, Mobile and Multimedia Networks” (WoWMoM), IEEE, Jun. 2019, pp. 1–6. doi: 10.1109/WoWMoM.2019.8793047.

N. Fotiou, I. Pittaras, V. A. Siris, S. Voulgaris, and G. C. Polyzos, “Secure IoT Access at Scale Using Blockchains and Smart Contracts,” in 2019 IEEE 20th International Symposium on “A World of Wireless, Mobile and Multimedia Networks” (WoWMoM), IEEE, Jun. 2019, pp. 1–6. doi: 10.1109/WoWMoM.2019.8793047.

X. Wang, “Research on Data Integrity Verification Technology Based on Blockchain,” J Phys Conf Ser, vol. 2035, no. 1, p. 012017, Sep. 2021, doi: 10.1088/1742-6596/2035/1/012017.

A. Alkhalifah, A. Ng, P. A. Watters, and A. S. M. Kayes, “A Mechanism to Detect and Prevent Ethereum Blockchain Smart Contract Reentrancy Attacks,” Front Comput Sci, vol. 3, Feb. 2021, doi: 10.3389/fcomp.2021.598780.

N. Fotiou and G. C. Polyzos, “Smart Contracts for the Internet of Things: Opportunities and Challenges,” in 2018 European Conference on Networks and Communications (EuCNC), IEEE, Jun. 2018, pp. 256–260. doi: 10.1109/EuCNC.2018.8443212.

K. T. Y. Mahima and T. N. D. S. Ginige, “A Secured Healthcare System Using Blockchain and Graph Theory,” in Proceedings of the 2020 4th International Symposium on Computer Science and Intelligent Control, New York, NY, USA: ACM, Nov. 2020, pp. 1–5. doi: 10.1145/3440084.3441217.

D. Yaga, P. Mell, N. Roby, and K. Scarfone, “Blockchain technology overview,” Gaithersburg, MD, Oct. 2018. doi: 10.6028/NIST.IR.8202.

V. Mehta and S. More, “Smart Contracts: Automated Stipulations on Blockchain,” in 2018 International Conference on Computer Communication and Informatics (ICCCI), IEEE, Jan. 2018, pp. 1–5. doi: 10.1109/ICCCI.2018.8441347.

X. Wang, “Research on Data Integrity Verification Technology Based on Blockchain,” J Phys Conf Ser, vol. 2035, no. 1, p. 012017, Sep. 2021, doi: 10.1088/1742-6596/2035/1/012017.

M. Aránguiz, A. Margheri, D. Xu, and B. Tran, “International Trade Revolution with Smart Contracts,” in The Digital Transformation of Logistics, Wiley, 2021, pp. 169–184. doi: 10.1002/9781119646495.ch12.

I. A. Omar, R. Jayaraman, K. Salah, and M. C. E. Simsekler, “Exploiting Ethereum Smart Contracts for Clinical Trial Management,” in 2019 IEEE/ACS 16th International Conference on Computer Systems and Applications (AICCSA), IEEE, Nov. 2019, pp. 1–6. doi: 10.1109/AICCSA47632.2019.9035341.

A. Demichev and A. Kryukov, “COMPLETE DECENTRALIZATION OF DISTRIBUTED DATA STORAGES BASED ON BLOCKCHAIN TECHNOLOGY,” in 9th International Conference “Distributed Computing and Grid Technologies in Science and Education,” Crossref, Dec. 2021, pp. 96–100. doi: 10.54546/MLIT.2021.77.48.001.

U. Rauf, M. Shehab, N. Qamar, and S. Sameen, “Formal approach to thwart against insider attacks: A bio-inspired auto-resilient policy regulation framework,” Future Generation Computer Systems, vol. 117, pp. 412–425, Apr. 2021, doi: 10.1016/j.future.2020.11.009.

I. A. Omar, R. Jayaraman, K. Salah, M. C. E. Simsekler, I. Yaqoob, and S. Ellahham, “Ensuring protocol compliance and data transparency in clinical trials using Blockchain smart contracts,” BMC Med Res Methodol, vol. 20, no. 1, p. 224, Dec. 2020, doi: 10.1186/s12874-020-01109-5.

F. Leal et al., “Smart Pharmaceutical Manufacturing: Ensuring End-to-End Traceability and Data Integrity in Medicine Production,” Big Data Research, vol. 24, p. 100172, May 2021, doi: 10.1016/j.bdr.2020.100172.

E. Solaiman, T. Wike, and I. Sfyrakis, “Implementation and evaluation of smart contracts using a hybrid on‐ and off‐blockchain architecture,” Concurr Comput, vol. 33, no. 1, Jan. 2021, doi: 10.1002/cpe.5811.

P. Pandey and R. Litoriya, “Securing and authenticating healthcare records through blockchain technology,” Cryptologia, vol. 44, no. 4, pp. 341–356, Jul. 2020, doi: 10.1080/01611194.2019.1706060.

I. A. Omar, R. Jayaraman, K. Salah, and M. C. E. Simsekler, “Exploiting Ethereum Smart Contracts for Clinical Trial Management,” in 2019 IEEE/ACS 16th International Conference on Computer Systems and Applications (AICCSA), IEEE, Nov. 2019, pp. 1–6. doi: 10.1109/AICCSA47632.2019.9035341.

Y. Zhang, X. Ding, and F. Hu, “Application and Development Prospect of Artificial Intelligence and Big Data in Medical and Health Field,” J Phys Conf Ser, vol. 1621, no. 1, p. 012108, Aug. 2020, doi: 10.1088/1742-6596/1621/1/012108.

S. Kolluri, J. Lin, R. Liu, Y. Zhang, and W. Zhang, “Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review,” AAPS J, vol. 24, no. 1, p. 19, Jan. 2022, doi: 10.1208/s12248-021-00644-3.

H. Pampel et al., “re3data – Indexing the Global Research Data Repository Landscape Since 2012,” Sci Data, vol. 10, no. 1, p. 571, Aug. 2023, doi: 10.1038/s41597-023-02462-y.

I. A. Omar, R. Jayaraman, K. Salah, M. C. E. Simsekler, I. Yaqoob, and S. Ellahham, “Ensuring protocol compliance and data transparency in clinical trials using Blockchain smart contracts,” BMC Med Res Methodol, vol. 20, no. 1, p. 224, Dec. 2020, doi: 10.1186/s12874-020-01109-5.

C. L. Gargalo et al., “Towards smart biomanufacturing: a perspective on recent developments in industrial measurement and monitoring technologies for bio-based production processes,” J Ind Microbiol Biotechnol, vol. 47, no. 11, pp. 947–964, Nov. 2020, doi: 10.1007/s10295-020-02308-1.

L. Martin, M. Hutchens, C. Hawkins, and A. Radnov, “How much do clinical trials cost?,” Nat Rev Drug Discov, vol. 16, no. 6, pp. 381–382, Jun. 2017, doi: 10.1038/nrd.2017.70.

C. L. Gargalo et al., “Towards smart biomanufacturing: a perspective on recent developments in industrial measurement and monitoring technologies for bio-based production processes,” J Ind Microbiol Biotechnol, vol. 47, no. 11, pp. 947–964, Nov. 2020, doi: 10.1007/s10295-020-02308-1.

I. A. Omar, R. Jayaraman, K. Salah, M. C. E. Simsekler, I. Yaqoob, and S. Ellahham, “Ensuring protocol compliance and data transparency in clinical trials using Blockchain smart contracts,” BMC Med Res Methodol, vol. 20, no. 1, p. 224, Dec. 2020, doi: 10.1186/s12874-020-01109-5.

I. A. Omar, R. Jayaraman, K. Salah, M. C. E. Simsekler, I. Yaqoob, and S. Ellahham, “Ensuring protocol compliance and data transparency in clinical trials using Blockchain smart contracts,” BMC Med Res Methodol, vol. 20, no. 1, p. 224, Dec. 2020, doi: 10.1186/s12874-020-01109-5.

J. M. DuBois, J. T. Chibnall, R. Tait, and J. S. Vander Wal, “The Professionalism and Integrity in Research Program: Description and Preliminary Outcomes,” Academic Medicine, vol. 93, no. 4, pp. 586–592, Apr. 2018, doi: 10.1097/ACM.0000000000001804.

K. Briggs, “Guidelines for FAIR sharing of preclinical safety and off-target pharmacology data,” ALTEX, 2021, doi: 10.14573/altex.2011181.

K. Briggs, “Guidelines for FAIR sharing of preclinical safety and off-target pharmacology data,” ALTEX, 2021, doi: 10.14573/altex.2011181.

S. Jangir, A. Muzumdar, A. Jaiswal, C. N. Modi, S. Chandel, and C. Vyjayanthi, “A Novel Framework for Pharmaceutical Supply Chain Management using Distributed Ledger and Smart Contracts,” in 2019 10th International Conference on Computing, Communication and Networking Technologies (ICCCNT), IEEE, Jul. 2019, pp. 1–7. doi: 10.1109/ICCCNT45670.2019.8944829.

I. A. Omar, R. Jayaraman, K. Salah, M. C. E. Simsekler, I. Yaqoob, and S. Ellahham, “Ensuring protocol compliance and data transparency in clinical trials using Blockchain smart contracts,” BMC Med Res Methodol, vol. 20, no. 1, p. 224, Dec. 2020, doi: 10.1186/s12874-020-01109-5.

I. A. Omar, R. Jayaraman, K. Salah, M. C. E. Simsekler, I. Yaqoob, and S. Ellahham, “Ensuring protocol compliance and data transparency in clinical trials using Blockchain smart contracts,” BMC Med Res Methodol, vol. 20, no. 1, p. 224, Dec. 2020, doi: 10.1186/s12874-020-01109-5.

A. Bohr and K. Memarzadeh, “The rise of artificial intelligence in healthcare applications,” in Artificial Intelligence in Healthcare, Elsevier, 2020, pp. 25–60. doi: 10.1016/B978-0-12-818438-7.00002-2.

C. Sillaber, B. Waltl, H. Treiblmaier, U. Gallersdörfer, and M. Felderer, “Laying the foundation for smart contract development: an integrated engineering process model,” Information Systems and e-Business Management, vol. 19, no. 3, pp. 863–882, Sep. 2021, doi: 10.1007/s10257-020-00465-5.

N. Tariq, A. Qamar, M. Asim, and F. A. Khan, “Blockchain and Smart Healthcare Security: A Survey,” Procedia Comput Sci, vol. 175, pp. 615–620, 2020, doi: 10.1016/j.procs.2020.07.089.

F. Cerreta et al., “Digital technologies for medicines: shaping a framework for success,” Nat Rev Drug Discov, vol. 19, no. 9, pp. 573–574, Sep. 2020, doi: 10.1038/d41573-020-00080-6.

N. Ensmenger, “Resistance Is Futile? Reluctant and Selective Users of the Internet,” in The Internet and American Business, The MIT Press, 2008, pp. 351–390. doi: 10.7551/mitpress/7495.003.0017.

N. Fotiou and G. C. Polyzos, “Smart Contracts for the Internet of Things: Opportunities and Challenges,” in 2018 European Conference on Networks and Communications (EuCNC), IEEE, Jun. 2018, pp. 256–260. doi: 10.1109/EuCNC.2018.8443212.

J. King, B. Smith, and L. Williams, “Audit Mechanisms in Electronic Health Record Systems,” Int J Comput Models Algorithms Med, vol. 3, no. 2, pp. 23–42, Apr. 2012, doi: 10.4018/jcmam.2012040102.

“Tools such as ChatGPT threaten transparent science; here are our ground rules for their use,” Nature, vol. 613, no. 7945, pp. 612–612, Jan. 2023, doi: 10.1038/d41586-023-00191-1.

R. Sheets, “Clinical Trial Ethics, Human Subjects Protections, and the Informed Consent Process,” in Fundamentals of Biologicals Regulation, Elsevier, 2018, pp. 317–334. doi: 10.1016/B978-0-12-809290-3.00018-3.

M. Arumugam, S. Deepa, G. R. Sreekanth, G. Arun, and S. Nilesh, “Counterfeit drugs prevention using block chain techniques,” IOP Conf Ser Mater Sci Eng, vol. 1055, no. 1, p. 012109, Feb. 2021, doi: 10.1088/1757-899X/1055/1/012109.

N. Josias Gbètoho Saho and E. C. Ezin, “Developing a Digital Healthcare Book based on the Blockchain Technology,” in 2021 International Symposium on Electrical, Electronics and Information Engineering, New York, NY, USA: ACM, Feb. 2021, pp. 617–622. doi: 10.1145/3459104.3459203.

B. REXHA, H. SADİKU, and B. KRASNİQİ, “Using Record Level Encryption for Securing Information in Classified Information Systems,” Nat Eng Sci, vol. 3, no. 2, pp. 207–224, May 2018, doi: 10.28978/nesciences.424677.

Dr. A. Radhakrishnan, “Secure Management of Health Care Data using Cloud Computing,” Int J Res Appl Sci Eng Technol, vol. 7, no. 3, pp. 386–390, Mar. 2019, doi: 10.22214/ijraset.2019.3067.

M. Z. A. Bhuiyan, A. Zaman, T. Wang, G. Wang, H. Tao, and M. M. Hassan, “Blockchain and Big Data to Transform the Healthcare,” in Proceedings of the International Conference on Data Processing and Applications, New York, NY, USA: ACM, May 2018, pp. 62–68. doi: 10.1145/3224207.3224220.

J. Wagner et al., “A dynamic map for learning, communicating, navigating and improving therapeutic development,” Nat Rev Drug Discov, vol. 17, no. 2, pp. 150–150, Feb. 2018, doi: 10.1038/nrd.2017.217.

A. Yogeshwar and S. Kamalakkannan, “Healthcare Domain in IoT with Blockchain Based Security- A Researcher’s Perspectives,” in 2021 5th International Conference on Intelligent Computing and Control Systems (ICICCS), IEEE, May 2021, pp. 1–9. doi: 10.1109/ICICCS51141.2021.9432198.

M. Attaran, “Blockchain technology in healthcare: Challenges and opportunities,” Int J Healthc Manag, vol. 15, no. 1, pp. 70–83, Jan. 2022, doi: 10.1080/20479700.2020.1843887.

J. Almalki, “State-of-the-Art Research in Blockchain of Things for HealthCare,” Arab J Sci Eng, vol. 49, no. 3, pp. 3163–3191, Mar. 2024, doi: 10.1007/s13369-023-07896-5.

I. Radanović and R. Likić, “Opportunities for Use of Blockchain Technology in Medicine,” Appl Health Econ Health Policy, vol. 16, no. 5, pp. 583–590, Oct. 2018, doi: 10.1007/s40258-018-0412-8.

B. K. Rai, “BBTCD: blockchain based traceability of counterfeited drugs,” Health Serv Outcomes Res Methodol, vol. 23, no. 3, pp. 337–353, Sep. 2023, doi: 10.1007/s10742-022-00292-w.

B. K. Rai, “BBTCD: blockchain based traceability of counterfeited drugs,” Health Serv Outcomes Res Methodol, vol. 23, no. 3, pp. 337–353, Sep. 2023, doi: 10.1007/s10742-022-00292-w.

I. Medvediev, O. Illiashenko, D. Uzun, and A. Strielkina, “IoT solutions for health monitoring: Analysis and case study,” in 2018 IEEE 9th International Conference on Dependable Systems, Services and Technologies (DESSERT), IEEE, May 2018, pp. 163–168. doi: 10.1109/DESSERT.2018.8409120.

B. Wagner, “Accountability by design in technology research,” Computer Law & Security Review, vol. 37, p. 105398, Jul. 2020, doi: 10.1016/j.clsr.2020.105398.

A. Thakre, F. Thabtah, S. R. Shahamiri, and S. Hammoud, “A novel block chain technology publication model proposal,” Applied Computing and Informatics, vol. 18, no. 3/4, pp. 195–207, Jun. 2022, doi: 10.1016/j.aci.2019.10.003.

I. A. Omar, R. Jayaraman, K. Salah, and M. C. E. Simsekler, “Exploiting Ethereum Smart Contracts for Clinical Trial Management,” in 2019 IEEE/ACS 16th International Conference on Computer Systems and Applications (AICCSA), IEEE, Nov. 2019, pp. 1–6. doi: 10.1109/AICCSA47632.2019.9035341.

I. A. Omar, R. Jayaraman, K. Salah, M. C. E. Simsekler, I. Yaqoob, and S. Ellahham, “Ensuring protocol compliance and data transparency in clinical trials using Blockchain smart contracts,” BMC Med Res Methodol, vol. 20, no. 1, p. 224, Dec. 2020, doi: 10.1186/s12874-020-01109-5.

D. A. Parasrampuria, L. Z. Benet, and A. Sharma, “Why Drugs Fail in Late Stages of Development: Case Study Analyses from the Last Decade and Recommendations,” AAPS J, vol. 20, no. 3, p. 46, May 2018, doi: 10.1208/s12248-018-0204-y.

K. Takenouchi et al., “Development of a new seamless data stream from EMR to EDC system using SS‐MIX2 standards applied for observational research in diabetes mellitus,” Learn Health Syst, vol. 3, no. 1, Jan. 2019, doi: 10.1002/lrh2.10072.

S. Jangir, A. Muzumdar, A. Jaiswal, C. N. Modi, S. Chandel, and C. Vyjayanthi, “A Novel Framework for Pharmaceutical Supply Chain Management using Distributed Ledger and Smart Contracts,” in 2019 10th International Conference on Computing, Communication and Networking Technologies (ICCCNT), IEEE, Jul. 2019, pp. 1–7. doi: 10.1109/ICCCNT45670.2019.8944829.

I. A. Omar, R. Jayaraman, K. Salah, and M. C. E. Simsekler, “Exploiting Ethereum Smart Contracts for Clinical Trial Management,” in 2019 IEEE/ACS 16th International Conference on Computer Systems and Applications (AICCSA), IEEE, Nov. 2019, pp. 1–6. doi: 10.1109/AICCSA47632.2019.9035341.

B. Hie, H. Cho, and B. Berger, “Realizing private and practical pharmacological collaboration,” Science (1979), vol. 362, no. 6412, pp. 347–350, Oct. 2018, doi: 10.1126/science.aat4807.

N. Fotiou and G. C. Polyzos, “Smart Contracts for the Internet of Things: Opportunities and Challenges,” in 2018 European Conference on Networks and Communications (EuCNC), IEEE, Jun. 2018, pp. 256–260. doi: 10.1109/EuCNC.2018.8443212.

R. T. Prabucki, “Self-executing Contracts from the perspective of the selected Polish regulations and the future potential prevalence of ‘Smarter’ Contracts,” The Journal of The British Blockchain Association, vol. 3, no. 2, pp. 1–7, Nov. 2020, doi: 10.31585/jbba-3-2-(3)2020.

I. A. Omar, R. Jayaraman, K. Salah, and M. C. E. Simsekler, “Exploiting Ethereum Smart Contracts for Clinical Trial Management,” in 2019 IEEE/ACS 16th International Conference on Computer Systems and Applications (AICCSA), IEEE, Nov. 2019, pp. 1–6. doi: 10.1109/AICCSA47632.2019.9035341.

I. A. Omar, R. Jayaraman, K. Salah, M. C. E. Simsekler, I. Yaqoob, and S. Ellahham, “Ensuring protocol compliance and data transparency in clinical trials using Blockchain smart contracts,” BMC Med Res Methodol, vol. 20, no. 1, p. 224, Dec. 2020, doi: 10.1186/s12874-020-01109-5.

F. Leal et al., “Smart Pharmaceutical Manufacturing: Ensuring End-to-End Traceability and Data Integrity in Medicine Production,” Big Data Research, vol. 24, p. 100172, May 2021, doi: 10.1016/j.bdr.2020.100172.

A. Premkumar and C. Srimathi, “Application of Blockchain and IoT towards Pharmaceutical Industry,” in 2020 6th International Conference on Advanced Computing and Communication Systems (ICACCS), IEEE, Mar. 2020, pp. 729–733. doi: 10.1109/ICACCS48705.2020.9074264.

I. A. Omar, R. Jayaraman, K. Salah, and M. C. E. Simsekler, “Exploiting Ethereum Smart Contracts for Clinical Trial Management,” in 2019 IEEE/ACS 16th International Conference on Computer Systems and Applications (AICCSA), IEEE, Nov. 2019, pp. 1–6. doi: 10.1109/AICCSA47632.2019.9035341.

A. K. M. B. Haque and B. Bhushan, “Blockchain in a Nutshell,” 2021, pp. 124–143. doi: 10.4018/978-1-7998-6694-7.ch009.

C. Sillaber, B. Waltl, H. Treiblmaier, U. Gallersdörfer, and M. Felderer, “Laying the foundation for smart contract development: an integrated engineering process model,” Information Systems and e-Business Management, vol. 19, no. 3, pp. 863–882, Sep. 2021, doi: 10.1007/s10257-020-00465-5.

I. A. Omar, R. Jayaraman, K. Salah, and M. C. E. Simsekler, “Exploiting Ethereum Smart Contracts for Clinical Trial Management,” in 2019 IEEE/ACS 16th International Conference on Computer Systems and Applications (AICCSA), IEEE, Nov. 2019, pp. 1–6. doi: 10.1109/AICCSA47632.2019.9035341.

S. Jangir, A. Muzumdar, A. Jaiswal, C. N. Modi, S. Chandel, and C. Vyjayanthi, “A Novel Framework for Pharmaceutical Supply Chain Management using Distributed Ledger and Smart Contracts,” in 2019 10th International Conference on Computing, Communication and Networking Technologies (ICCCNT), IEEE, Jul. 2019, pp. 1–7. doi: 10.1109/ICCCNT45670.2019.8944829.

Downloads

Published

2024-04-29

How to Cite

Elsa Wulandari, A. N., & Purwono. (2024). Smart Contracts for Data Sharing in Drug Development a Systematic Review of Security and Transparent Measurement. Journal of Advanced Health Informatics Research, 2(1), 24–37. https://doi.org/10.59247/jahir.v2i1.288

Issue

Vol. 2 No. 1 (2024)

Section

Articles

License

Copyright (c) 2024 Annastasya Nabila Elsa Wulandari, Purwono

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

All articles published in the JAHIR Journal are licensed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. This license grants the following permissions and obligations:

1. Permitted Uses:

  • Sharing – You may copy and redistribute the material in any medium or format.
  • Adaptation – You may remix, transform, and build upon the material for any purpose, including commercial use.

2. Conditions of Use:

  • Attribution – You must give appropriate credit to the original author(s), provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in a way that suggests the licensor endorses you or your use.
  • ShareAlike – If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original (CC BY-SA 4.0).
  • No Additional Restrictions – You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

3. Disclaimer:

  • The JAHIR Journal and the authors are not responsible for any modifications, interpretations, or derivative works made by third parties using the published content.
  • This license does not affect the ownership of copyrights, and authors retain full rights to their work.

For further details, please refer to the official Creative Commons Attribution-ShareAlike 4.0 International License.

Most read articles by the same author(s)